UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 153

Sortiert nach

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Clinical infectious diseases, 2008-07, Vol.47 (2), p.266-285

2008

Volltextzugriff (PDF)

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

American journal of respiratory and critical care medicine, 2008-01, Vol.177 (1), p.108-113

2008

Volltextzugriff (PDF)

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

JAMA : the journal of the American Medical Association, 2008-08, Vol.300 (5), p.555

2008

Volltextzugriff (PDF)

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118

2012

Volltextzugriff (PDF)

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel

JAMA : the journal of the American Medical Association, 2006-08, Vol.296 (7), p.827

2006

Volltextzugriff (PDF)

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596

2013

Volltextzugriff (PDF)

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (2), p.251

2004

Volltextzugriff (PDF)

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 2002-07, Vol.288 (2), p.222

2002

Volltextzugriff (PDF)

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients : 24-week results of POWER 1

AIDS (London), 2007-02, Vol.21 (4), p.395-402

2007

Volltextzugriff (PDF)

Gag Cytotoxic T Lymphocyte Escape Mutations Can Increase Sensitivity of HIV-1 to Human TRIM5α, Linking Intrinsic and Acquired Immunity

Journal of Virology, 2011-11, Vol.85 (22), p.11846-11854

2011

Volltextzugriff (PDF)

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 2000-01, Vol.283 (3), p.381

2000

Volltextzugriff (PDF)

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Antiviral therapy, 2014-01, Vol.19 (2), p.191-200

2014

Volltextzugriff (PDF)

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up

PloS one, 2015-07, Vol.10 (7), p.e0134430-e0134430

2015

Volltextzugriff (PDF)

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART[S]

Journal of lipid research, 2015-03, Vol.56 (3), p.692-702

2015

Volltextzugriff (PDF)

Enfuvirtide: from basic investigations to current clinical use

Expert opinion on pharmacotherapy, 2010-11, Vol.11 (16), p.2701-2713

2010

Volltextzugriff (PDF)

Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report

AIDS (London), 2014-08, Vol.28 (13), p.1995-1997

2014

Volltextzugriff (PDF)

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (1), p.78

1998

Volltextzugriff (PDF)

[18F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis

Frontiers in medicine, 2021-08, Vol.8, p.715115-715115

2021

Volltextzugriff (PDF)

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts

PloS one, 2013-08, Vol.8 (8), p.e71473-e71473

2013

Volltextzugriff (PDF)

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.758-765

2013

Volltextzugriff (PDF)

Update on HAART in HIV

Journal of hepatology, 2006, Vol.44 (1 Suppl), p.S100-S103

Yeni, Patrick

2006

Volltextzugriff (PDF)

Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient

PLoS neglected tropical diseases, 2012-10, Vol.6 (10), p.e1802-e1802

2012

Volltextzugriff (PDF)

Positive Impact of HIV-1 gag Cleavage Site Mutations on the Virological Response to Darunavir Boosted with Ritonavir

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1754-1757

2011

Volltextzugriff (PDF)

Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.172-175

2004

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(117)
Humans
(115)
Life Sciences & Biomedicine
(112)
Infectious Diseases
(99)
Hiv Infections - Drug Therapy
(78)
Male
(78)
Biological And Medical Sciences
(72)
Female
(70)
Medical Sciences
(70)
Adult
(68)
Human Immunodeficiency Virus
(57)
Hiv
(50)
Human Viral Diseases
(49)
Viral Diseases
(49)
Middle Aged
(46)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(44)
Microbiology
(43)
Pharmacology. Drug Treatments
(42)
Virology
(41)
Hiv Infections - Virology
(40)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients : 24-week results of POWER 1

Gag Cytotoxic T Lymphocyte Escape Mutations Can Increase Sensitivity of HIV-1 to Human TRIM5α, Linking Intrinsic and Acquired Immunity

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART[S]

Enfuvirtide: from basic investigations to current clinical use

Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

[18F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

Update on HAART in HIV

Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient

Positive Impact of HIV-1 gag Cleavage Site Mutations on the Virological Response to Darunavir Boosted with Ritonavir

Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs

Suchergebnisse filtern